Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 212 articles:
HTML format



Single Articles


    November 2021
  1. GANDHI PU, Windish DM
    Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
    J Am Coll Cardiol. 2021;78:2265-2266.
    PubMed    


  2. PALAU P, Seller J, Dominguez E, Sastre C, et al
    Effect of beta-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2042-2056.
    PubMed     Abstract available


  3. GOTTLIEB SH
    Heart Failure With Reduced Ejection Fraction: "Guideline-Directed Medical Therapy (GDMT)" Versus "The Art of Medicine".
    J Am Coll Cardiol. 2021;78:2013-2016.
    PubMed    


  4. RAO VN, Murray E, Butler J, Cooper LB, et al
    In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2004-2012.
    PubMed     Abstract available


  5. KINDEL SJ
    Pediatric Data for Pediatric Heart Failure: Stepping Out on Our Own.
    J Am Coll Cardiol. 2021;78:1901-1903.
    PubMed    


    October 2021
  6. KLEINER SHOCHAT M, Fudim M, Kapustin D, Kazatsker M, et al
    Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;78:1751-1752.
    PubMed    


  7. RANGASWAMI J, Lo KB, Vaduganathan M, Mathew RO, et al
    Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.
    J Am Coll Cardiol. 2021;78:1669-1670.
    PubMed    


  8. KENCHAIAH S, Budoff MJ, Ding J, Carr JJ, et al
    Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
    J Am Coll Cardiol. 2021;78:e113-e115.
    PubMed    


  9. BONAPACE S, Molon G, Marinelli A, Lanzoni L, et al
    Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
    J Am Coll Cardiol. 2021;78:e111.
    PubMed    


    September 2021
  10. BOHM M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.
    J Am Coll Cardiol. 2021;78:1337-1348.
    PubMed     Abstract available


  11. CUNNINGHAM JW, Myhre PL
    NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate.
    J Am Coll Cardiol. 2021;78:1333-1336.
    PubMed    


  12. PANDEY A, Shah SJ, Butler J, Kellogg DL Jr, et al
    Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1166-1187.
    PubMed     Abstract available


    August 2021
  13. FUDIM M, Abraham WT, von Bardeleben RS, Lindenfeld J, et al
    Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:931-956.
    PubMed     Abstract available


  14. HERSBERGER L, Stanga Z, Schuetz P
    Reply: The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:856-857.
    PubMed    


  15. IKOMA T, Saito H, Oka T, Maekawa Y, et al
    The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:855-856.
    PubMed    


  16. DROZD M, Cubbon RM
    Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
    J Am Coll Cardiol. 2021;78:760.
    PubMed    


  17. SHEN L, Jhund PS, McMurray JJV
    Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
    J Am Coll Cardiol. 2021;78:760-761.
    PubMed    


  18. MEWTON N, Baudry G, Sebbag L
    Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
    J Am Coll Cardiol. 2021;78:759.
    PubMed    


  19. BROCH K, Anstensrud AK, Woxholt S, Andersen GO, et al
    Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637-638.
    PubMed    


  20. DEL BUONO MG, Van Tassell BW, Abbate A
    Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637.
    PubMed    


  21. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
    Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
    J Am Coll Cardiol. 2021;78:543-544.
    PubMed    


  22. SHCHENDRYGINA A, Mewton N, Meznar AZ
    Advanced Heart Failure and Angiotensin System Fascinating Complexities.
    J Am Coll Cardiol. 2021;78:541-542.
    PubMed    


    July 2021
  23. ROSSIGNOL P, Pitt B
    Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
    J Am Coll Cardiol. 2021;78:344-347.
    PubMed    


  24. ITKIN M, Rockson SG, Burkhoff D
    Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:278-290.
    PubMed     Abstract available


  25. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
    Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:66-76.
    PubMed     Abstract available


  26. FUSTER JJ
    Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
    J Am Coll Cardiol. 2021;78:53-55.
    PubMed    


  27. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
    Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    J Am Coll Cardiol. 2021;78:42-52.
    PubMed     Abstract available


  28. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
    Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
    J Am Coll Cardiol. 2021;78:14-23.
    PubMed     Abstract available


    June 2021
  29. LAM CSP, Solomon SD
    Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:3217-3225.
    PubMed     Abstract available


  30. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    PubMed    


  31. HINKEL R, Batkai S, Bahr A, Bozoglu T, et al
    AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
    J Am Coll Cardiol. 2021;77:2923-2935.
    PubMed     Abstract available


  32. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    PubMed     Abstract available


  33. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
    Pericardial Fat and the Risk of Heart Failure.
    J Am Coll Cardiol. 2021;77:2638-2652.
    PubMed     Abstract available


    May 2021
  34. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    PubMed     Abstract available


  35. GOTTLIEB SH
    Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
    J Am Coll Cardiol. 2021;77:2320-2322.
    PubMed    


  36. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
    Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
    J Am Coll Cardiol. 2021;77:2307-2319.
    PubMed     Abstract available


  37. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
    New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
    J Am Coll Cardiol. 2021;77:2260-2262.
    PubMed    


  38. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
    Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
    PubMed     Abstract available


    April 2021
  39. MANCINI D, Gibson GT
    Impact of Pneumonia in Heart Failure Patients.
    J Am Coll Cardiol. 2021;77:1974-1976.
    PubMed    


  40. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
    Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1961-1973.
    PubMed     Abstract available


  41. HONKA H, Solis-Herrera C, Triplitt C, Norton L, et al
    Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2022-2039.
    PubMed     Abstract available


  42. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
    Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1952-1953.
    PubMed    


  43. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    PubMed    


  44. RAUH MJ
    Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2021;77:1760-1762.
    PubMed    


  45. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
    Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1747-1759.
    PubMed     Abstract available


  46. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
    Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
    J Am Coll Cardiol. 2021;77:1731-1743.
    PubMed     Abstract available


  47. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
    Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    J Am Coll Cardiol. 2021;77:1717-1727.
    PubMed     Abstract available


    March 2021
  48. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
    Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
    J Am Coll Cardiol. 2021;77:1454-1469.
    PubMed     Abstract available


  49. GREENE SJ, Khan MS
    Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
    J Am Coll Cardiol. 2021;77:1408-1411.
    PubMed    


  50. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
    Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
    J Am Coll Cardiol. 2021;77:1397-1407.
    PubMed     Abstract available


  51. KOSIBOROD MN, Vaduganathan M
    SGLT-2 Inhibitors in Heart Failure: Volume or Value?
    J Am Coll Cardiol. 2021;77:1393-1396.
    PubMed    


  52. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;77:1381-1392.
    PubMed     Abstract available


  53. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
    TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
    J Am Coll Cardiol. 2021;77:1481-1483.
    PubMed    


  54. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
    SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
    J Am Coll Cardiol. 2021;77:1375-1377.
    PubMed    


  55. MCCULLOUGH PA, Rahimi G, Tecson KM
    Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1222-1224.
    PubMed    


  56. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
    Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    J Am Coll Cardiol. 2021;77:1211-1221.
    PubMed     Abstract available


  57. BALTHAZAR T, Vandenbriele C, Verbrugge FH, Den Uil C, et al
    Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:1243-1256.
    PubMed     Abstract available


  58. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
    3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1029-1040.
    PubMed     Abstract available


  59. KOFOED KF, Engstrom T, Sigvardsen PE, Linde JJ, et al
    Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2021;77:1044-1052.
    PubMed     Abstract available


    February 2021
  60. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
    Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
    J Am Coll Cardiol. 2021;77:1023-1025.
    PubMed    


  61. FELKER GM, Greene SJ
    Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
    J Am Coll Cardiol. 2021;77:709-712.
    PubMed    


  62. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
    Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:695-708.
    PubMed     Abstract available


  63. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
    Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2021;77:713-724.
    PubMed     Abstract available


  64. GOODLIN SJ
    RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
    J Am Coll Cardiol. 2021;77:504-505.
    PubMed    


  65. CHUZI S, Khan SS, Pak ES
    Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
    J Am Coll Cardiol. 2021;77:501-505.
    PubMed    


  66. FRISK M, Le C, Shen X, Roe AT, et al
    Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:405-419.
    PubMed     Abstract available


  67. HULOT JS, Livrozet M
    HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
    J Am Coll Cardiol. 2021;77:420-422.
    PubMed    


    January 2021
  68. GOLDBERG LR
    The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
    J Am Coll Cardiol. 2021;77:256-258.
    PubMed    


  69. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
    Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
    J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
    PubMed    


  70. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
    J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
    PubMed    


    December 2020
  71. PAGANI FD
    Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
    J Am Coll Cardiol. 2020;76:2965-2967.
    PubMed    


  72. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
    Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
    J Am Coll Cardiol. 2020;76:2940-2951.
    PubMed     Abstract available


  73. ALAHMAD B, Khraishah H
    Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
    J Am Coll Cardiol. 2020;76:2875-2877.
    PubMed    


  74. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
    Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
    J Am Coll Cardiol. 2020;76:2862-2874.
    PubMed     Abstract available


  75. GUPTA DK, Crescenzi R, Aday AW
    Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2830-2833.
    PubMed    


  76. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
    Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2817-2829.
    PubMed     Abstract available


  77. JANUZZI JL JR, Ibrahim NE
    Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
    J Am Coll Cardiol. 2020;76:2752-2754.
    PubMed    


  78. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
    Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2740-2751.
    PubMed     Abstract available


  79. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
    Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:2671-2681.
    PubMed     Abstract available


  80. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
    Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:2595-2606.
    PubMed     Abstract available


    November 2020
  81. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
    2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
    PubMed    


  82. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
    Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
    J Am Coll Cardiol. 2020;76:2334-2348.
    PubMed     Abstract available


  83. FASELIS C, Fonarow GC, Ahmed A
    Reply: Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418-2420.
    PubMed    


  84. DAUW J, Mullens W
    Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418.
    PubMed    


  85. PANJRATH GS, Krepp J
    COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
    J Am Coll Cardiol. 2020;76:2349-2351.
    PubMed    


  86. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
    Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2417-2418.
    PubMed    


  87. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
    Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2416-2417.
    PubMed    


  88. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
    Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
    PubMed     Abstract available


  89. VELAZQUEZ EJ, Reinhardt SW
    Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
    J Am Coll Cardiol. 2020;76:2086-2088.
    PubMed    


    October 2020
  90. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
    Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2040-2041.
    PubMed    


  91. FUDIM M, Soloveva A
    Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2038-2039.
    PubMed    


  92. LIU PP, Al-Khalaf M, Blet A
    Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
    J Am Coll Cardiol. 2020;76:1995-1998.
    PubMed    


  93. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
    Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1982-1994.
    PubMed     Abstract available


  94. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
    Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
    J Am Coll Cardiol. 2020;76:1919-1930.
    PubMed     Abstract available


  95. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
    2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
    PubMed    


  96. KITTLESON MM
    The Trials of Women in Cardiology.
    J Am Coll Cardiol. 2020;76:1931-1933.
    PubMed    


  97. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
    Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1795-1807.
    PubMed     Abstract available


  98. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
    Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
    J Am Coll Cardiol. 2020;76:1717-1718.
    PubMed    


  99. MEWTON N, Sebbag L, Bochaton T
    Other Things Behind the Low Rate of Heart Failure Trial Publication.
    J Am Coll Cardiol. 2020;76:1716-1717.
    PubMed    


  100. MEHMOOD M
    Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
    J Am Coll Cardiol. 2020;76:1715-1716.
    PubMed    


    September 2020
  101. SUTHAHAR N, Lau ES, Blaha MJ, Paniagua SM, et al
    Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.
    J Am Coll Cardiol. 2020;76:1455-1465.
    PubMed     Abstract available


  102. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
    Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
    J Am Coll Cardiol. 2020;76:1501-1502.
    PubMed    


  103. XIANG D, Xiang X, Zhang W, Yi S, et al
    Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
    J Am Coll Cardiol. 2020;76:1318-1324.
    PubMed     Abstract available


  104. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
    Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:1305-1314.
    PubMed     Abstract available


  105. KOSMALA W
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: How to Fight Allied Enemies.
    J Am Coll Cardiol. 2020;76:1065-1067.
    PubMed    


  106. REDDY YNV, Obokata M, Verbrugge FH, Lin G, et al
    Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1051-1064.
    PubMed     Abstract available


  107. AMBROSY AP, Braunwald E, Morrow DA, DeVore AD, et al
    Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.
    J Am Coll Cardiol. 2020;76:1034-1048.
    PubMed     Abstract available


  108. GOTTLIEB SS, Ahmed T
    Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
    J Am Coll Cardiol. 2020;76:1049-1050.
    PubMed    


  109. GUAZZI M, Ghio S, Adir Y
    Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1102-1111.
    PubMed     Abstract available


  110. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
    Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;76:1084-1101.
    PubMed     Abstract available


    August 2020
  111. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
    Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    J Am Coll Cardiol. 2020;76:930-941.
    PubMed     Abstract available


  112. SANNINO A, Sudhakaran S, Milligan G, Chowdhury A, et al
    Effectiveness of Medical Therapy for Functional Mitral Regurgitation in Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:883-884.
    PubMed    


  113. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    PubMed     Abstract available


  114. ROWIN EJ, Maron BJ, Maron MS
    The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36310.
    PubMed    


  115. DALZELL JR, Connolly EC, Cannon JA
    The LVAD in the management of advanced heart failure due to hypertrophic cardiomyopathy.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36312.
    PubMed    


  116. BUTLER J, Khan MS
    Heart Failure Prevention for All: Treatment Is Good, Prevention Is Better.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36305.
    PubMed    


  117. WILCOX JE, Fang JC, Margulies KB, Mann DL, et al
    Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2020;76:719-734.
    PubMed     Abstract available


  118. FASELIS C, Arundel C, Patel S, Lam PH, et al
    Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    J Am Coll Cardiol. 2020;76:669-679.
    PubMed     Abstract available


  119. COX ZL, Stevenson LW
    The Weight of Evidence for Diuretics and Parachutes.
    J Am Coll Cardiol. 2020;76:680-683.
    PubMed    


  120. BAYES-GENIS A, Nunez J, Lupon J
    Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
    J Am Coll Cardiol. 2020;76:515-517.
    PubMed    


  121. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
    Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
    J Am Coll Cardiol. 2020;76:503-514.
    PubMed     Abstract available


    July 2020
  122. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    PubMed     Abstract available


  123. ZILE MR, Lindenfeld J, Weaver FA, Zannad F, et al
    Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1-13.
    PubMed     Abstract available


  124. JANUZZI JL JR, Ibrahim NE
    The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
    J Am Coll Cardiol. 2020;76:14-16.
    PubMed    


    June 2020
  125. PSOTKA MA, Latta F, Cani D, Fiuzat M, et al
    Publication Rates of Heart Failure Clinical Trials Remain Low.
    J Am Coll Cardiol. 2020;75:3151-3161.
    PubMed     Abstract available


  126. MEHRA MR, Grazette LP
    Untimely Trial Publication: A Sin of Omission?
    J Am Coll Cardiol. 2020;75:3162-3163.
    PubMed    


  127. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
    Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    J Am Coll Cardiol. 2020;75:3033-3043.
    PubMed     Abstract available


  128. KAPUR NK
    RESPONSE: Hybrid Training for Interventional, Heart Failure, and Critical Care Medicine.
    J Am Coll Cardiol. 2020;75:2987-2988.
    PubMed    


  129. SOMERS VK, Karim S
    Upright Cheyne-Stokes Respiration in Heart Failure: Look But Don't Touch.
    J Am Coll Cardiol. 2020;75:2947-2949.
    PubMed    


  130. GIANNONI A, Gentile F, Sciarrone P, Borrelli C, et al
    Upright Cheyne-Stokes Respiration in Patients With Heart Failure.
    J Am Coll Cardiol. 2020;75:2934-2946.
    PubMed     Abstract available


  131. PARKER WF, Chung K, Anderson AS, Siegler M, et al
    Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
    J Am Coll Cardiol. 2020;75:2906-2916.
    PubMed     Abstract available


  132. FERREIRA JP, Butler J, Rossignol P, Pitt B, et al
    Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:2836-2850.
    PubMed     Abstract available


  133. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
    Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:2851-2862.
    PubMed     Abstract available


    May 2020
  134. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
    Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
    J Am Coll Cardiol. 2020;75:2642-2644.
    PubMed    


  135. JAVAHERI A, Allegood JC, Cowart LA, Chirinos JA, et al
    Circulating Ceramide 16:0 in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;75:2273-2275.
    PubMed    


  136. MEINERTZ T, Munzel T
    Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
    J Am Coll Cardiol. 2020;75:2107-2109.
    PubMed    


    April 2020
  137. HULOT JS, Masurkar N
    miRNA-Based Therapeutics for Heart Failure: Why Not?
    J Am Coll Cardiol. 2020;75:1801-1803.
    PubMed    


  138. REDFORS B, Furer A, Selker HP, Thiele H, et al
    Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    J Am Coll Cardiol. 2020;75:1743-1754.
    PubMed     Abstract available


    March 2020
  139. STEVENSON LW, Naftilan AJ
    Changing the Stage Directions for Heart Failure?
    J Am Coll Cardiol. 2020;75:1439-1442.
    PubMed    


  140. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
    Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1501-1502.
    PubMed    


  141. PALAZZUOLI A, Ruocco G
    Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1500-1501.
    PubMed    


  142. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
    Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1471-1487.
    PubMed     Abstract available


  143. NIJST P, Martens P, Dauw J, Tang WHW, et al
    Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2020;75:1426-1438.
    PubMed     Abstract available


  144. MURPHY SP, Kakkar R, McCarthy CP, Januzzi JL Jr, et al
    Inflammation in Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1324-1340.
    PubMed     Abstract available


  145. CHIRINOS JA, Orlenko A, Zhao L, Basso MD, et al
    Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;75:1281-1295.
    PubMed     Abstract available


  146. ALEXANDER CM
    Is Heart Failure Still the Frequent, Forgotten, and Often Fatal Complication of Diabetes?
    J Am Coll Cardiol. 2020;75:1263-1265.
    PubMed    


  147. KITZMAN DW, Upadhya B, Felker GM
    A Biomarker Approach to Understanding HFpEF.
    J Am Coll Cardiol. 2020;75:1296-1298.
    PubMed    


  148. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
    Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
    J Am Coll Cardiol. 2020;75:1249-1262.
    PubMed     Abstract available


  149. PIRRUCCELLO JP, Bick A, Chaffin M, Aragam KG, et al
    Titin Truncating Variants in Adults Without Known Congestive Heart Failure.
    J Am Coll Cardiol. 2020;75:1239-1241.
    PubMed    


  150. FELKER GM, Ellison DH, Mullens W, Cox ZL, et al
    Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1178-1195.
    PubMed     Abstract available


  151. DEC GW
    Which Drug Will "Lead" in Reducing Cardiac Events Among Heart Failure Patients With Diabetes?
    J Am Coll Cardiol. 2020;75:1142-1144.
    PubMed    


  152. MARSO SP, Baeres FMM, Bain SC, Goldman B, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.
    J Am Coll Cardiol. 2020;75:1128-1141.
    PubMed     Abstract available


  153. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
    Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
    J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
    PubMed    


  154. PAULUS WJ
    Adhesion molecules in early adulthood predict heart failure with preserved ejection fraction at older age.
    J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)34549.
    PubMed    


  155. SELVARAJ S, Claggett BL, Bohm M, Anker SD, et al
    Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.
    J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)30518.
    PubMed     Abstract available


  156. VENTURA HO, Lavie CJ, Mehra MR
    Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal.
    J Am Coll Cardiol. 2020 Mar 10. pii: S0735-1097(20)30620.
    PubMed    


  157. SABBATINI AR, Kararigas G
    Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:1074-1082.
    PubMed     Abstract available


  158. ARNOLD SV, Stone GW, Mack MJ, Chhatriwalla AK, et al
    Health Status Changes and Outcomes in Patients with Heart Failure and Mitral Regurgitation: From COAPT.
    J Am Coll Cardiol. 2020 Mar 4. pii: S0735-1097(20)34413.
    PubMed     Abstract available


  159. BUGIARDINI R, Manfrini O, Cenko E
    Reply: Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction: The Role of S-Nitrosylation.
    J Am Coll Cardiol. 2020;75:989.
    PubMed    


  160. PATANE S
    Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction: The Role of S-Nitrosylation.
    J Am Coll Cardiol. 2020;75:988-989.
    PubMed    


    February 2020
  161. KO DT, Khera R, Lau G, Qiu F, et al
    Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure.
    J Am Coll Cardiol. 2020;75:736-746.
    PubMed     Abstract available


  162. WASFY JH
    A Health Policy and Care Delivery Crisis That We Must Understand Then Fix.
    J Am Coll Cardiol. 2020;75:747-749.
    PubMed    


  163. YANCY CW, Drazner MH, Coffin ST, Cornwell W 3rd, et al
    2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee.
    J Am Coll Cardiol. 2020 Feb 14. pii: S0735-1097(19)37741.
    PubMed    


  164. ZELNIKER TA, Braunwald E
    Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:422-434.
    PubMed     Abstract available


  165. LEE SP, Suh HY, Park S, Oh S, et al
    Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    J Am Coll Cardiol. 2020;75:380-390.
    PubMed     Abstract available


  166. SALDEN FCWM, Luermans JGLM, Westra SW, Weijs B, et al
    Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.
    J Am Coll Cardiol. 2020;75:347-359.
    PubMed     Abstract available


    January 2020
  167. VENTURA HO, Lavie CJ, Mehra MR
    Heart Failure With Preserved Ejection Fraction: Separating the Wheat From the Chaff.
    J Am Coll Cardiol. 2020;75:255-257.
    PubMed    


  168. GOLDHABER SZ
    Venous Thromboembolism in Heart Failure Patients: Pathophysiology, Predictability, Prevention.
    J Am Coll Cardiol. 2020;75:159-162.
    PubMed    


  169. FANOLA CL, Norby FL, Shah AM, Chang PP, et al
    Incident Heart Failure and Long-Term Risk for Venous Thromboembolism.
    J Am Coll Cardiol. 2020;75:148-158.
    PubMed     Abstract available


  170. BISBAL F, Baranchuk A, Braunwald E, Bayes de Luna A, et al
    Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:222-232.
    PubMed     Abstract available


    December 2019
  171. DESWAL A
    Heart Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint.
    J Am Coll Cardiol. 2019;74:2905-2907.
    PubMed    


  172. KOTECHA D, Gill SK, Flather MD, Holmes J, et al
    Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2893-2904.
    PubMed     Abstract available


  173. SHAH AM, Cikes M, Prasad N, Li G, et al
    Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2858-2873.
    PubMed     Abstract available


  174. FONAROW GC, Masson R, Ahmed A
    Reply: What Is Important for Digoxin Treatment in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2827-2828.
    PubMed    


  175. TAN J, Mai L, Zhang Y, Wu Y, et al
    What Is Important for Digoxin Treatment in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2827.
    PubMed    


    November 2019
  176. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    PubMed     Abstract available


  177. CENKO E, van der Schaar M, Yoon J, Manfrini O, et al
    Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:2379-2389.
    PubMed     Abstract available


  178. BRILLER J
    The Feminine Mystique in Myocardial Infarction Associated Mortality.
    J Am Coll Cardiol. 2019;74:2390-2391.
    PubMed    


  179. VADUGANATHAN M, Fonarow GC, Greene SJ, DeVore AD, et al
    Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38082.
    PubMed    


  180. VADUGANATHAN M, Claggett BL, Desai AS, Anker SD, et al
    Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38299.
    PubMed     Abstract available


  181. MARTYN T, Faulkenberg KD, Yaranov DM, Albert CL, et al
    Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output.
    J Am Coll Cardiol. 2019;74:2326-2327.
    PubMed    


  182. GIVERTZ MM, DeFilippis EM, Landzberg MJ, Pinney SP, et al
    Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:2295-2312.
    PubMed     Abstract available


  183. CIAMPI Q, Zagatina A, Cortigiani L, Gaibazzi N, et al
    Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography.
    J Am Coll Cardiol. 2019;74:2278-2291.
    PubMed     Abstract available


    October 2019
  184. AIMO A, Januzzi JL Jr, Bayes-Genis A, Vergaro G, et al
    Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2193-2203.
    PubMed     Abstract available


  185. SUN J, Shang H, Yang X, Xing Y, et al
    Effect of Cardioprotective Drugs on Chemotherapy-Induced Heart Failure and New Risk Stratification.
    J Am Coll Cardiol. 2019;74:1736.
    PubMed    


  186. GOLDSTEIN NE, Mather H, McKendrick K, Gelfman LP, et al
    Improving Communication in Heart Failure Patient Care.
    J Am Coll Cardiol. 2019;74:1682-1692.
    PubMed     Abstract available


    September 2019
  187. ASCH FM, Grayburn PA, Siegel RJ, Kar S, et al
    Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial.
    J Am Coll Cardiol. 2019 Sep 19. pii: S0735-1097(19)37678.
    PubMed     Abstract available


    June 2019
  188. VERGARO G, Passino C, Emdin M
    No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril.
    J Am Coll Cardiol. 2019;73:3037-3038.
    PubMed    


  189. RUBERG FL, Grogan M, Hanna M, Kelly JW, et al
    Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2872-2891.
    PubMed     Abstract available


  190. SALLOUM FN, Chau VQ
    Osteopontin in HFpEF: More Than Just a Remodeling-Specific Biomarker.
    J Am Coll Cardiol. 2019;73:2719-2721.
    PubMed    


  191. YOUSEFI K, Irion CI, Takeuchi LM, Ding W, et al
    Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
    J Am Coll Cardiol. 2019;73:2705-2718.
    PubMed     Abstract available


    May 2019
  192. BARTKO PE, Arfsten H, Heitzinger G, Pavo N, et al
    A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:2506-2517.
    PubMed     Abstract available


  193. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    PubMed     Abstract available


  194. DANIELS LB, Bui QM
    Should a High Gal-3 Have Us Scared Stiff?
    J Am Coll Cardiol. 2019;73:2296-2298.
    PubMed    


  195. FRANGOGIANNIS NG
    Can Myocardial Fibrosis Be Reversed?
    J Am Coll Cardiol. 2019;73:2283-2285.
    PubMed    


  196. STIENEN S, Ferreira JP, Vincent J, Busselen M, et al
    Estimated Long-Term Survival With Eplerenone.
    J Am Coll Cardiol. 2019;73:2357-2359.
    PubMed    


  197. PSOTKA MA, Gottlieb SS, Francis GS, Allen LA, et al
    Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2345-2353.
    PubMed     Abstract available


  198. ASLEH R, Enriquez-Sarano M, Jaffe AS, Manemann SM, et al
    Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    J Am Coll Cardiol. 2019;73:2286-2295.
    PubMed     Abstract available


  199. IUNG B, Messika-Zeitoun D
    Transcatheter Mitral Valve Repair in Secondary MR: New Findings and New Challenges.
    J Am Coll Cardiol. 2019;73:2133-2134.
    PubMed    


  200. WELLS QS, Gupta DK, Smith JG, Collins SP, et al
    Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.
    J Am Coll Cardiol. 2019;73:2195-2205.
    PubMed     Abstract available


  201. SCHLICHTING LE, Insaf TZ, Zaidi AN, Lui GK, et al
    Maternal Comorbidities and Complications of Delivery in Pregnant Women With Congenital Heart Disease.
    J Am Coll Cardiol. 2019;73:2181-2191.
    PubMed     Abstract available


    April 2019
  202. LEHRKE M
    SGLT2 Inhibition: Changing What Fuels the Heart.
    J Am Coll Cardiol. 2019;73:1945-1947.
    PubMed    


  203. HAUSENLOY DJ, Heusch G
    Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST Action.
    J Am Coll Cardiol. 2019;73:2001-2003.
    PubMed    


  204. THOMAS L, Marwick TH, Popescu BA, Donal E, et al
    Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:1961-1977.
    PubMed     Abstract available


  205. MORROW DA
    The Changing Face of Cardiogenic Shock: A Challenge in Cardiac Critical Care.
    J Am Coll Cardiol. 2019;73:1792-1794.
    PubMed    


    March 2019
  206. IBRAHIM NE, McCarthy CP, Shrestha S, Gaggin HK, et al
    Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
    J Am Coll Cardiol. 2019;73:1273-1284.
    PubMed     Abstract available


  207. MYHRE PL, Vaduganathan M, Claggett B, Packer M, et al
    B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    J Am Coll Cardiol. 2019;73:1264-1272.
    PubMed     Abstract available


  208. SUCHAROV CC, Nakano SJ, Slavov D, Schwisow JA, et al
    A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.
    J Am Coll Cardiol. 2019;73:1173-1184.
    PubMed     Abstract available


  209. BRESS AP, King JB
    Optimizing Medical Therapy in Chronic Worsening HFrEF: A Long Way to Go.
    J Am Coll Cardiol. 2019;73:945-947.
    PubMed    


  210. VERMA S, Wanner C, Zwiener I, Ofstad AP, et al
    Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2019 Mar 5. pii: S0735-1097(19)33807.
    PubMed    


    February 2019
  211. ZANNAD F, Ferreira JP
    Is Sacubitril/Valsartan Antifibrotic?
    J Am Coll Cardiol. 2019;73:807-809.
    PubMed    


  212. ZILE MR, O'Meara E, Claggett B, Prescott MF, et al
    Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
    J Am Coll Cardiol. 2019;73:795-806.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: